American International Group, Inc. Stoke Therapeutics, Inc. Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 13,738 shares of STOK stock, worth $176,258. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,738

Previous 13,711 0.2%

Holding current value

$176,258

Previous $72,000 156.94%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$4.12 - $14.17 $111 - $382	27 Added 0.2%	13,738 $185,000
Q4 2023 Feb 13, 2024	SELL	$3.37 - $5.4 $188 - $302	-56 Reduced 0.41%	13,711 $72,000
Q3 2023 Nov 13, 2023	BUY	$3.78 - $11.99 $1,852 - $5,875	490 Added 3.69%	13,767 $54,000
Q2 2023 Aug 04, 2023	BUY	$7.93 - $13.82 $19,380 - $33,776	2,444 Added 22.56%	13,277 $141,000
Q1 2023 May 12, 2023	BUY	$7.65 - $10.38 $1,652 - $2,242	216 Added 2.03%	10,833 $90,000

Q4 2022 Feb 10, 2023	SELL	$7.07 - $15.69 $275 - $611	-39 Reduced 0.37%	10,617 $97,000
Q3 2022 Nov 14, 2022	BUY	$12.56 - $22.53 $1,884 - $3,379	150 Added 1.43%	10,656 $137,000
Q2 2022 Aug 12, 2022	BUY	$10.36 - $23.93 $10,660 - $24,623	1,029 Added 10.86%	10,506 $139,000
Q1 2022 May 13, 2022	SELL	$17.19 - $26.1 $11,465 - $17,408	-667 Reduced 6.58%	9,477 $199,000
Q4 2021 Feb 11, 2022	SELL	$18.11 - $30.72 $5,505 - $9,338	-304 Reduced 2.91%	10,144 $243,000
Q3 2021 Nov 12, 2021	SELL	$23.65 - $34.44 $5,865 - $8,541	-248 Reduced 2.32%	10,448 $266,000
Q2 2021 Aug 13, 2021	BUY	$30.53 - $41.09 $85,178 - $114,641	2,790 Added 35.29%	10,696 $360,000
Q1 2021 May 07, 2021	BUY	$36.08 - $69.81 $25,039 - $48,448	694 Added 9.62%	7,906 $307,000
Q4 2020 Feb 12, 2021	SELL	$33.62 - $61.93 $3,126 - $5,759	-93 Reduced 1.27%	7,212 $447,000
Q3 2020 Nov 04, 2020	SELL	$22.23 - $37.48 $3,690 - $6,221	-166 Reduced 2.22%	7,305 $245,000
Q2 2020 Aug 12, 2020	SELL	$20.26 - $29.73 $52,635 - $77,238	-2,598 Reduced 25.8%	7,471 $178,000
Q1 2020 May 04, 2020	BUY	$16.8 - $34.15 $72,861 - $148,108	4,337 Added 75.66%	10,069 $231,000
Q4 2019 Feb 05, 2020	SELL	$20.01 - $30.79 $960 - $1,477	-48 Reduced 0.83%	5,732 $162,000
Q3 2019 Nov 08, 2019	BUY	$20.53 - $37.72 $118,663 - $218,021	5,780 New	5,780 $124,000

Others Institutions Holding STOK

# of Institutions

111

Shares Held

50M

Call Options Held

63K

Put Options Held

111K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $506M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Stoke Therapeutics, Inc. Transaction History